| 1 |
Chi ZC. Progress in research of low-grade inflammation in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(24): 1051-1065 [DOI: 10.11569/wcjd.v30.i24.1051] [Reference Citation Analysis]
|
| 2 |
Xu Y, Xu H, Wang X, Wen H, Guan H, Gao F, Xu H, Jing W, Li J, Mei Y, Li W, Chen Q, Liu F, Cui H. Network-Based Elaboration of the Efficacy of the Dachangshu (BL25) and Tianshu (ST25) Points in the Treatment of Functional Constipation in Children through Inflammation, Adipocytokine, or Leptin Pathways. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/5315927] [Reference Citation Analysis]
|
| 3 |
Sharifi M, Safarpour AR, Barati-Boldaji R, Rahmati L, Karimi S, Bagheri Lankaran K. Post-Infectious Irritable Bowel Syndrome after an Epidemic of Gastroenteritis in South of Iran. Middle East J Dig Dis 2022;14:304-9. [PMID: 36619262 DOI: 10.34172/mejdd.2022.287] [Reference Citation Analysis]
|
| 4 |
Hasler WL, Grabauskas G, Singh P, Owyang C. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome. Neurogastroenterol Motil 2022;34:e14339. [PMID: 35315179 DOI: 10.1111/nmo.14339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Levy EI, De Geyter C, Ouald Chaib A, Aman BA, Hegar B, Vandenplas Y. How to manage irritable bowel syndrome in children. Acta Paediatr 2022;111:24-34. [PMID: 34525233 DOI: 10.1111/apa.16107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Ivashkin KV, Grechishnikova VR, Reshetova MS, Ivashkin VT. Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2021;31:54-63. [DOI: 10.22416/1382-4376-2021-31-1-54-63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Sánchez-morales G, Rojas-gutiérrez E, González-martínez C, Bonilla-salas A, Yamamoto-furusho J. The most highly cited articles of the Revista de Gastroenterología de México over a 22-year period (1996-2018). Revista de Gastroenterología de México (English Edition) 2021;86:59-69. [DOI: 10.1016/j.rgmxen.2020.10.008] [Reference Citation Analysis]
|
| 8 |
Kovaleva AL, Poluektova EA, Shifrin OS. Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2020;30:52-59. [DOI: 10.22416/1382-4376-2020-30-4-52-59] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Qin H, Yao L, Wang X, Wang Q, Tian J, Kwong JS, Wu T, Zhao Xiang B; Cochrane Gut Group. 5-aminosalicylic acid analogues for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013723] [Reference Citation Analysis]
|
| 10 |
Cheng W, Li J, Liu X. 5-Aminosalicylic acid for treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19351. [PMID: 32118774 DOI: 10.1097/MD.0000000000019351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Cıralı C, Ulusoy E, Kume T, Arslan N. Elevated serum neopterin levels in children with functional constipation: association with systemic proinflammatory cytokines. World J Pediatr 2018;14:448-53. [PMID: 29549607 DOI: 10.1007/s12519-018-0144-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Ma XX, Wang FY, Tang XD. Role of mast cell activation and degranulation in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2017; 25(29): 2637-2644 [DOI: 10.11569/wcjd.v25.i29.2637] [Reference Citation Analysis]
|
| 13 |
Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 15.2] [Reference Citation Analysis]
|
| 14 |
Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017; 23(37): 6788-6801 [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 15 |
Fan W, Ding C, Xu N, Zong S, Ma P, Gu B. Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis 2017;36:2303-17. [DOI: 10.1007/s10096-017-3060-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Han K, Wang J, Seo JG, Kim H. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol 2017;52:432-43. [PMID: 27178566 DOI: 10.1007/s00535-016-1224-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 17 |
Distrutti E, Monaldi L, Ricci P, Fiorucci S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol 2016; 22(7): 2219-2241 [PMID: 26900286 DOI: 10.3748/wjg.v22.i7.2219] [Cited by in CrossRef: 204] [Cited by in F6Publishing: 210] [Article Influence: 29.1] [Reference Citation Analysis]
|
| 18 |
Rachel D. Moloney, Anthony C. Johnson, Siobhain M. O'Mahony, Timothy G. Dinan, Beverley Greenwood‐Van Meerveld, John F. Cryan. Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neurosci Ther 2015;22. [PMID: 26662472 DOI: 10.1111/cns.12490] [Cited by in Crossref: 203] [Cited by in F6Publishing: 194] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 19 |
Shimura S, Ishimura N, Mikami H, Okimoto E, Uno G, Tamagawa Y, Aimi M, Oshima N, Sato S, Ishihara S. Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders. J Neurogastroenterol Motil. 2016;22:60-68. [PMID: 26554916 DOI: 10.5056/jnm15116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 20 |
Ponziani FR, Gerardi V, Pecere S, D’Aversa F, Lopetuso L, Zocco MA, Pompili M, Gasbarrini A. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. World J Gastroenterol 2015; 21(43): 12322-12333 [PMID: 26604640 DOI: 10.3748/wjg.v21.i43.12322] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 21 |
Lu XF, Zhang SS. Role of mast cells in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2015; 23(14): 2239-2244 [DOI: 10.11569/wcjd.v23.i14.2239] [Reference Citation Analysis]
|
| 22 |
Orduna P, Lopez SY, Schmulson M, Arredondo R, Ponce de Leon S, Lopez-Vidal Y. A survey using the social networks revealed poor knowledge on fecal microbiota transplantation. J Neurogastroenterol Motil 2015;21:294-5. [PMID: 25843083 DOI: 10.5056/jnm14146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 23 |
Moloney RD, O'Mahony SM, Dinan TG, Cryan JF. Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry 2015;6:15. [PMID: 25762939 DOI: 10.3389/fpsyt.2015.00015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 12.8] [Reference Citation Analysis]
|
